Literature DB >> 30166347

Activation loop phosphorylation of ERK3 is important for its kinase activity and ability to promote lung cancer cell invasiveness.

Lobna Elkhadragy1, Hadel Alsaran1, Marion Morel1, Weiwen Long2.   

Abstract

ERK3 is an atypical mitogen-activated protein kinase (MAPK) that has recently gained interest for its role in promoting cancer cell migration and invasion. However, the molecular regulation of ERK3 functions in cancer cells is largely unknown. ERK3 has a single phospho-acceptor site (Ser189) in its activation motif rather than the TXY conserved in conventional MAPKs such as ERK1/2. Although dual phosphorylation of the TXY motif is known to be critical for the activation of conventional MAPKs, the role of Ser189 phosphorylation in ERK3 activity and its function in cancer cells remain elusive. In this study, we revealed that activation loop phosphorylation is important for ERK3 in promoting cancer cell invasiveness, as the S189A mutation greatly decreased the ability of ERK3 to promote migration and invasion of lung cancer cells. Interestingly, a catalytically inactive ERK3 mutant was still capable of increasing migration and invasion, although to a lesser extent compared with WT ERK3, suggesting that ERK3 promotes cancer cell invasiveness by both kinase-dependent and kinase-independent mechanisms. To elucidate how the S189A mutation reduces the invasiveness-promoting ability of ERK3, we tested its effect on the kinase activity of ERK3 toward steroid receptor coactivator 3 (SRC3), a recently identified substrate of ERK3 critical for cancer cell invasiveness. Compared with ERK3, ERK3-S189A exhibited a dramatic decrease in kinase activity toward SRC3 and a concomitantly reduced ability to stimulate matrix metalloproteinase expression. Taken together, our study unravels the importance of Ser189 phosphorylation for intramolecular regulation of ERK3 kinase activity and invasiveness-promoting ability in lung cancer cells.
© 2018 Elkhadragy et al.

Entities:  

Keywords:  activation loop phosphorylation; cell invasion; cell migration; extracellular signal–regulated kinase (ERK); lung cancer; mitogen-activated protein kinase (MAPK)

Mesh:

Substances:

Year:  2018        PMID: 30166347      PMCID: PMC6200930          DOI: 10.1074/jbc.RA118.003699

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  32 in total

1.  Increased expression of mitogen-activated protein kinase and its upstream regulating signal in human gastric cancer.

Authors:  Bin Liang; Shan Wang; Xue-Guang Zhu; Yong-Xiang Yu; Zhi-Rong Cui; You-Zhi Yu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  Activation loop phosphorylation of ERK3/ERK4 by group I p21-activated kinases (PAKs) defines a novel PAK-ERK3/4-MAPK-activated protein kinase 5 signaling pathway.

Authors:  Paul Déléris; Matthias Trost; Ivan Topisirovic; Pierre-Luc Tanguay; Katherine L B Borden; Pierre Thibault; Sylvain Meloche
Journal:  J Biol Chem       Date:  2010-12-22       Impact factor: 5.157

3.  ERK3 signals through SRC-3 coactivator to promote human lung cancer cell invasion.

Authors:  Weiwen Long; Charles E Foulds; Jun Qin; Jian Liu; Chen Ding; David M Lonard; Luisa M Solis; Ignacio I Wistuba; Jun Qin; Sophia Y Tsai; Ming-Jer Tsai; Bert W O'Malley
Journal:  J Clin Invest       Date:  2012-04-16       Impact factor: 14.808

4.  Molecular cloning, isolation and characterisation of ERK3 gene from chewing-tobacco induced oral squamous cell carcinoma.

Authors:  Rekha Rai; Alka Mahale; Dhananjaya Saranath
Journal:  Oral Oncol       Date:  2004-08       Impact factor: 5.337

5.  Induction of p97MAPK expression regulates collagen mediated inhibition of proliferation and migration in human squamous cell carcinoma lines.

Authors:  David L Crowe
Journal:  Int J Oncol       Date:  2004-05       Impact factor: 5.650

6.  Loss of Erk3 function in mice leads to intrauterine growth restriction, pulmonary immaturity, and neonatal lethality.

Authors:  Sonia Klinger; Benjamin Turgeon; Kim Lévesque; Geoffrey A Wood; Kjersti M Aagaard-Tillery; Sylvain Meloche
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-15       Impact factor: 11.205

Review 7.  The structural basis for control of eukaryotic protein kinases.

Authors:  Jane A Endicott; Martin E M Noble; Louise N Johnson
Journal:  Annu Rev Biochem       Date:  2012-04-05       Impact factor: 23.643

8.  Tumour promoting and suppressing roles of the atypical MAP kinase signalling pathway ERK3/4-MK5.

Authors:  Sergiy Kostenko; Gianina Dumitriu; Ugo Moens
Journal:  J Mol Signal       Date:  2012-07-16

9.  Regulation of atypical MAP kinases ERK3 and ERK4 by the phosphatase DUSP2.

Authors:  Maria Perander; Rania Al-Mahdi; Thomas C Jensen; Jennifer A L Nunn; Hanne Kildalsen; Bjarne Johansen; Mads Gabrielsen; Stephen M Keyse; Ole-Morten Seternes
Journal:  Sci Rep       Date:  2017-03-02       Impact factor: 4.379

10.  L290P/V mutations increase ERK3's cytoplasmic localization and migration/invasion-promoting capability in cancer cells.

Authors:  Hadel Alsaran; Lobna Elkhadragy; Astha Shakya; Weiwen Long
Journal:  Sci Rep       Date:  2017-11-03       Impact factor: 4.379

View more
  11 in total

1.  The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7.

Authors:  Marion Morel; Krushangi N Shah; Weiwen Long
Journal:  J Biol Chem       Date:  2020-04-28       Impact factor: 5.157

2.  ERK3/MAPK6 controls IL-8 production and chemotaxis.

Authors:  Katarzyna Bogucka; Malvika Pompaiah; Federico Marini; Harald Binder; Gregory Harms; Manuel Kaulich; Matthias Klein; Christian Michel; Markus P Radsak; Sebastian Rosigkeit; Peter Grimminger; Hansjörg Schild; Krishnaraj Rajalingam
Journal:  Elife       Date:  2020-04-21       Impact factor: 8.140

3.  Identification of atypical mitogen-activated protein kinase MAPK4 as a novel regulator in acute lung injury.

Authors:  Ling Mao; Ya Zhou; Longqing Chen; Lin Hu; Shiming Liu; Wen Zheng; Juanjuan Zhao; Mengmeng Guo; Chao Chen; Zhixu He; Lin Xu
Journal:  Cell Biosci       Date:  2020-10-19       Impact factor: 7.133

4.  A Radioactive in vitro ERK3 Kinase Assay.

Authors:  Lobna Elkhadragy; Weiwen Long
Journal:  Bio Protoc       Date:  2019-08-20

5.  Phosphorylation of steroid receptor coactivator-3 (SRC-3) at serine 857 is regulated by the p38MAPK-MK2 axis and affects NF-κB-mediated transcription.

Authors:  Anup Shrestha; Henrike Bruckmueller; Hanne Kildalsen; Gurjit Kaur; Matthias Gaestel; Hilde Ljones Wetting; Ingvild Mikkola; Ole-Morten Seternes
Journal:  Sci Rep       Date:  2020-07-09       Impact factor: 4.379

Review 6.  Extracellular-Signal Regulated Kinase: A Central Molecule Driving Epithelial-Mesenchymal Transition in Cancer.

Authors:  Monserrat Olea-Flores; Miriam Daniela Zuñiga-Eulogio; Miguel Angel Mendoza-Catalán; Hugo Alberto Rodríguez-Ruiz; Eduardo Castañeda-Saucedo; Carlos Ortuño-Pineda; Teresita Padilla-Benavides; Napoleón Navarro-Tito
Journal:  Int J Mol Sci       Date:  2019-06-13       Impact factor: 5.923

7.  ERK3 is transcriptionally upregulated by ∆Np63α and mediates the role of ∆Np63α in suppressing cell migration in non-melanoma skin cancers.

Authors:  Eid S Alshammari; Amjad A Aljagthmi; Andrew J Stacy; Mike Bottomley; H Nicholas Shamma; Madhavi P Kadakia; Weiwen Long
Journal:  BMC Cancer       Date:  2021-02-12       Impact factor: 4.430

8.  Conditional ERK3 overexpression cooperates with PTEN deletion to promote lung adenocarcinoma formation in mice.

Authors:  Sreeram Vallabhaneni; Jian Liu; Marion Morel; Jixin Wang; Francesco J DeMayo; Weiwen Long
Journal:  Mol Oncol       Date:  2021-12-14       Impact factor: 6.603

9.  ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.

Authors:  Katarzyna Bogucka; Federico Marini; Sebastian Rosigkeit; Janine Schloeder; Helmut Jonuleit; Kerstin David; Margarita Schlackow; Krishnaraj Rajalingam
Journal:  Cancer Gene Ther       Date:  2020-10-17       Impact factor: 5.987

10.  The C-Terminus Tail Regulates ERK3 Kinase Activity and Its Ability in Promoting Cancer Cell Migration and Invasion.

Authors:  Lobna Elkhadragy; Hadel Alsaran; Weiwen Long
Journal:  Int J Mol Sci       Date:  2020-06-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.